Back
Apellis Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
29.28
Seasonality Move:
20.78%
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
66.13
Seasonality Move:
13.04%
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.12. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.26
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 52.74 | Buy |
Chaikin Money Flow: | 179519 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.95 - 28.71) | Buy |
Bollinger Bands (100): | (29.49 - 39.35) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 33.22 | Sell |
Chaikin Money Flow: | -314047 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.74 - 70.42) | Sell |
Bollinger Bands (100): | (70.34 - 87.98) | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.88 | Buy |
20-day SMA: | 28.02 | Buy |
50-day SMA: | 30.86 | Sell |
200-day SMA: | 43.85 | Sell |
8-day EMA: | 28.92 | Buy |
20-day EMA: | 28.61 | Buy |
50-day EMA: | 30.58 | Sell |
200-day EMA: | 40.41 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.41 | Sell |
20-day SMA: | 68.28 | Sell |
50-day SMA: | 72.14 | Sell |
200-day SMA: | 82.07 | Sell |
8-day EMA: | 66.71 | Sell |
20-day EMA: | 68.01 | Sell |
50-day EMA: | 72.04 | Sell |
200-day EMA: | 80.69 | Sell |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Apellis Pharmaceuticals Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |